Dr. Chris Palmer theorizes that the metabolic and neurological side effects of antipsychotic medications may be a primary mechanism of their therapeutic action, achieved through the inhibition of brai...

According to Dr. Chris Palmer, the rates of severe bipolar disorder in youth and young adults have doubled in the last 20 years, which he attributes to environmental rather than genetic problems.

According to Dr. Chris Palmer, the ketogenic diet is a 100-year-old, evidence-based treatment for epilepsy that can stop seizures even when medications are ineffective.

Dr. Chris Palmer's first patient with schizoaffective disorder, who had unsuccessfully tried 17 different medications, experienced a remission of hallucinations and paranoid delusions approximately tw...

There are over 25 controlled trials recently completed or currently underway studying the ketogenic diet as a treatment for severe mental illness.

A study following children from birth to age 24 found that those with the highest levels of insulin resistance at age 9 were five times more likely to develop a psychosis-at-risk mental state.

A randomized controlled trial of the ketogenic diet for depression was recently published in JAMA Psychiatry.

The ketogenic diet is known to improve mitochondrial function and stimulate autophagy, a process where defective mitochondria are recycled and new ones are made.

The Wellcome Trust has funded a $10 million study of the ketogenic diet as a treatment for bipolar disorder, which will be the largest dietary intervention ever studied for the condition.

Publications from two recently completed randomized controlled trials of the ketogenic diet for schizophrenia are expected within the next six months, and the results are described as "overwhelmingly ...

Children with the highest levels of insulin resistance at age 9 were found to be three times more likely to be diagnosed with bipolar disorder or schizophrenia by age 24.

Insurance companies, including Medicare and Medicaid, will not pay for patients with mental illness to see a dietitian.

Clinical trials are currently underway to evaluate GLP-1 agonists like Ozempic and Wegovy for the treatment of Alzheimer's disease, bipolar disorder, schizophrenia, depression, and various addictions.

A woman named Doris, who had schizophrenia for 53 years, achieved remission within six months of starting a ketogenic diet, was able to discontinue all antipsychotic medications, and remained well for...

Medicare will not pay for a patient to see a dietitian for obesity, but it will cover the cost of GLP-1 receptor agonists, which can be over $1,000 per month.